199 related articles for article (PubMed ID: 20847296)
1. Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice.
Volynets V; Spruss A; Kanuri G; Wagnerberger S; Bischoff SC; Bergheim I
J Lipid Res; 2010 Dec; 51(12):3414-24. PubMed ID: 20847296
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
[TBL] [Abstract][Full Text] [Related]
3. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice.
Haub S; Kanuri G; Volynets V; Brune T; Bischoff SC; Bergheim I
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G335-44. PubMed ID: 19713474
[TBL] [Abstract][Full Text] [Related]
4. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.
Spruss A; Kanuri G; Stahl C; Bischoff SC; Bergheim I
Lab Invest; 2012 Jul; 92(7):1020-32. PubMed ID: 22525431
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.
Wagnerberger S; Spruss A; Kanuri G; Volynets V; Stahl C; Bischoff SC; Bergheim I
Br J Nutr; 2012 Jun; 107(12):1727-38. PubMed ID: 22018861
[TBL] [Abstract][Full Text] [Related]
6. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.
Kanuri G; Spruss A; Wagnerberger S; Bischoff SC; Bergheim I
J Nutr Biochem; 2011 Jun; 22(6):527-34. PubMed ID: 20801629
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
[TBL] [Abstract][Full Text] [Related]
8. Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction.
Liu X; Xue R; Ji L; Zhang X; Wu J; Gu J; Zhou M; Chen S
Biochem Biophys Res Commun; 2014 Jul; 450(1):117-23. PubMed ID: 24875360
[TBL] [Abstract][Full Text] [Related]
9. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice.
Spruss A; Kanuri G; Uebel K; Bischoff SC; Bergheim I
Antioxid Redox Signal; 2011 Jun; 14(11):2121-35. PubMed ID: 21083420
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.
Bergheim I; Weber S; Vos M; Krämer S; Volynets V; Kaserouni S; McClain CJ; Bischoff SC
J Hepatol; 2008 Jun; 48(6):983-92. PubMed ID: 18395289
[TBL] [Abstract][Full Text] [Related]
11. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
Donepudi AC; Boehme S; Li F; Chiang JY
Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
[TBL] [Abstract][Full Text] [Related]
12. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
13. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
14. Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.
Kanuri G; Spruss A; Wagnerberger S; Bischoff SC; Bergheim I
Lab Invest; 2011 Jun; 91(6):885-95. PubMed ID: 21423135
[TBL] [Abstract][Full Text] [Related]
15. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
Spruss A; Henkel J; Kanuri G; Blank D; Püschel GP; Bischoff SC; Bergheim I
Mol Med; 2012 Dec; 18(1):1346-55. PubMed ID: 22952059
[TBL] [Abstract][Full Text] [Related]
16. FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model.
Kunne C; Acco A; Duijst S; de Waart DR; Paulusma CC; Gaemers I; Oude Elferink RP
Biochim Biophys Acta; 2014 May; 1842(5):739-46. PubMed ID: 24548803
[TBL] [Abstract][Full Text] [Related]
17. Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat.
Kamisako T; Ogawa H; Yamamoto K
J Gastroenterol Hepatol; 2007 Nov; 22(11):1832-7. PubMed ID: 17498222
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.
Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK
J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
Zhai Y; Zhou W; Yan X; Qiao Y; Guan L; Zhang Z; Liu H; Jiang J; Liu J; Peng L
Phytomedicine; 2022 Dec; 107():154444. PubMed ID: 36155217
[TBL] [Abstract][Full Text] [Related]
20. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
